文献速递主动脉疾病

修复时机与胸主动脉腔内修复治疗壁内血肿结局的关联

The association of repair timing on outcomes following thoracic endovascular aortic repair for intramural hematoma.
PubMed 文献 · J Vasc Surg · 2025-08-11

本研究比较了因壁内血肿行急诊TEVAR(入院24小时内)与择期TEVAR(超过24小时)患者的结局。共纳入345例患者,其中165例(48%)接受择期修复。急诊组围手术期死亡率和再干预率显著更高,但5年生存率差异无统计学意义。在症状性患者中,急诊组围手术期死亡率、急性肾损伤和再干预率均显著更高。

要点

  • 急诊TEVAR(24小时内)较择期TEVAR围手术期死亡率更高(6.3% vs 0.6%)。
  • 急诊组再干预率更高(8.3% vs 2.4%),择期组住院时间更长。
  • 症状性患者中急诊TEVAR的围手术期死亡、急性肾损伤和再干预风险显著增加。

核心结论

  • 急诊TEVAR治疗IMH的围手术期结局劣于择期TEVAR,尽管基线风险相当。
  • 数据支持优先稳定病情后再干预的管理策略,但某些病例仍需急诊修复。

研究设计与样本

  • 回顾性队列研究,纳入2013至2023年因IMH行TEVAR(主动脉 zones 2-5)的患者,排除破裂者。
  • 共345例患者,165例(48%)接受择期修复,采用倾向评分调整后比较急诊与择期TEVAR的结局。

临床怎么用

  • 对IMH患者应优先考虑稳定病情后再行TEVAR,而非紧急干预。
  • 急诊TEVAR仅用于必要的病例,并需警惕围手术期死亡、急性肾损伤和再干预风险。

局限性

  • 5年生存率差异无统计学意义,可能受样本量限制。
  • 回顾性设计可能存在选择偏倚,尽管使用了倾向评分调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Intramural hematoma (IMH) carries significant risk of morbidity and mortality, and although thoracic endovascular aortic repair (TEVAR) is increasingly used as a treatment, the optimal timing for its intervention remains uncertain. This study aimed to compare outcomes between patients undergoing urgent TEVAR (within 24 hours of admission) and those undergoing elective TEVAR (beyond 24 hours from admission). METHODS: Patients who underwent TEVAR between aortic zones 2 and 5 for IMH from 2013 to 2023 were included, excluding those with rupture. Propensity scores were generated using covariates such as age, sex, race, obesity, anemia, transfer status, hypertension, diabetes, prior myocardial infarction, congestive heart failure, smoking history, chronic obstructive pulmonary disease, cerebrovascular disease, dialysis status, medication use, and previous aortic surgery, to adjust for assignment to urgent/emergent or elective TEVAR. Perioperative outcomes were assessed using inverse probability-weighted logistic regression. Association of urgent or elective TEVAR with 5-year mortality was assessed using Cox regression stratified by IMH symptom status. RESULTS: Among 345 patients, 165 (48%) underwent elective repair. The urgent group had a higher rate of transfers from outside institutions (64% vs 43%; P = .01), were less likely to use beta-blockers before presentation (69% vs 84%; P = .003), and were more frequently symptomatic at presentation (98% vs 72%; P < .001). There were no significant differences in IMH disease extent or graft landing zones between groups. Perioperative mortality (6.3% vs 0.6%; adjusted odds ratio [aOR] 19; 95% confidence interval [CI], 3.01-764; P = .02) and reintervention during index admission (8.3% vs 2.4%; aOR, 4.92; 95% CI, 1.67-19.5; P = .01) was significantly greater in the urgent group. Five-year survival was lower in the urgent group, but this difference was not statistically significant. In symptomatic patients, the urgent cohort had significantly higher perioperative mortality (7.3% vs 0.8%; aOR, 10; 95% CI, 2.11-152; P = .02), acute kidney injury (9.0% vs 2.5%; aOR, 3.28; 95% CI, 1.12-12.1; P = .04), and reintervention (8.5% vs 2.5%; aOR, 5.26; 95% CI, 1.61-25.6; P = .01) rates. Conversely, the elective group had a longer total length of stay (32% vs 21%; aOR, 0.48; 95% CI, 0.28-0.82; P = .01). Five-year survival in the symptomatic cohort was lower in the urgent group, but this difference was not statistically significant. CONCLUSIONS: Patients undergoing urgent TEVAR for IMH experience worse perioperative outcomes compared with those undergoing elective repairs, despite comparable baseline risk profiles. Although emergent repair may be necessary in certain cases, these data advocate for a patient management strategy that prioritizes stabilization before intervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Manchella MK, Rastogi V, Bellomo TR, et al. The association of repair timing on outcomes following thoracic endovascular aortic repair for intramural hematoma. J Vasc Surg. 2025. PMID: 40803598. doi:10.1016/j.jvs.2025.08.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。